Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Gastroenterology and hepatology indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Whipple disease and tropical malabsorption

Gastroenterology and hepatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull

Overview

Recognise Whipple disease and travel-related malabsorption without collapsing them into a single tropical diagnosis, select tissue, molecular and stool tests with microbiology, and begin prolonged organism-specific therapy only with infection and gastroenterology expertise using current reference-laboratory, UKHSA, BNF and local imported-infection guidance.

Whipple disease is a rare chronic infection by T. whipplei, an actinomycete-related organism. The classic sequence is intermittent arthralgia followed years later by diarrhoea, weight loss, fever, lymphadenopathy, abdominal pain, hyperpigmentation or oedema. Cardiac, central nervous system, ocular and focal joint disease may dominate. Histology typically shows foamy macrophages in the lamina propria containing PAS-positive material, but treated or extra-intestinal disease can be patchy and other organisms can mimic the stain.

PCR increases sensitivity but changes meaning by compartment. Detection in saliva or stool can occur in asymptomatic carriage and is insufficient alone. Concordant duodenal tissue histology and PCR are stronger; blood, synovial fluid, valve tissue, vitreous or cerebrospinal fluid is selected for the clinical phenotype. Diagnosis should be agreed with a reference microbiology service because specimen handling, assay and contamination affect interpretation.

Travel-related malabsorption begins with a timeline rather than the obsolete assumption that residence in the tropics proves tropical sprue. Protozoa, helminths, HIV, TB, post-infectious change, coeliac disease unmasked during travel and inflammatory bowel disease all compete. Tropical sprue remains a diagnosis of exclusion in people with chronic diarrhoea and small-bowel mucosal injury in relevant endemic settings after infections and coeliac disease are excluded. Treatment and duration are specialist-led because relapse and resistance consequences are substantial.

Key points

  • Classic Whipple disease is caused by Tropheryma whipplei and often presents with years of migratory seronegative arthralgia before weight loss, diarrhoea, abdominal pain, nodes or systemic disease.
  • Neurological, ocular and culture-negative endocarditis presentations can occur without obvious diarrhoea; cognitive change, supranuclear gaze disorder or oculomasticatory movements are high-risk clues.
  • Duodenal histology with PAS-positive macrophages plus organism-specific PCR on appropriately chosen samples supports diagnosis; stool or saliva PCR alone can reflect carriage.
  • Exclude Whipple disease before escalating immunosuppression in a credible multisystem inflammatory mimic because corticosteroids or biologics can accelerate infection.
  • Tropical malabsorption is a syndrome, not an aetiology: travel geography, duration, food and water, freshwater, barefoot soil, medicines, immune state and onset guide testing.
  • Giardia, Strongyloides, HIV-related infection, intestinal tuberculosis, coeliac disease and pancreatic disease are generally more defensible targets than assuming tropical sprue.
  • UK SMI guidance supports Giardia and Cryptosporidium in primary testing for symptomatic diarrhoea, with travel- and immune-specific parasite investigations added explicitly.

Aetiology

01

Tropheryma whipplei infection

Classic Whipple disease results from invasive T. whipplei infection in a small susceptible subset of exposed or colonised people.

02

Host immune susceptibility

Impaired organism-specific cellular clearance permits macrophage accumulation and systemic dissemination; carriage alone does not establish invasive disease.

03

Travel-related enteric disease

Giardiasis, helminth infection, tropical sprue and HIV-associated enteropathy are distinct imported causes of malabsorption requiring exposure-specific testing.

Pathophysiology

  1. 1
    Macrophage-laden villous infiltration

    T. whipplei accumulates within PAS-positive lamina-propria macrophages, distorting villi and impairing small-intestinal nutrient and lymphatic transport.

  2. 2
    Systemic dissemination

    Organisms spread to joints, heart, nervous system, eyes and lymph nodes, sometimes years before or without obvious diarrhoea.

  3. 3
    Alternative tropical mucosal injury

    Other imported infections damage villi, consume nutrients or cause chronic inflammation through organism-specific rather than Whipple mechanisms.

Clinical features and red flags

Classic Whipple sequence

Migratory large-joint arthralgia predates diarrhoea, weight loss, abdominal pain, fever or nodes in a middle-aged adult; seronegative inflammatory labels may already be present.

Neurological Whipple diseaseRed flag

Cognitive or behavioural change, ataxia, hypothalamic features, supranuclear gaze palsy, myoclonus or oculomasticatory movements requires urgent CNS-aware diagnostic and treatment planning.

Culture-negative endocarditisRed flag

Valvular infection, embolic phenomena or heart failure with negative routine cultures can be T. whipplei even without gut symptoms; valve tissue PCR may be decisive.

Imported parasitic malabsorption

Persistent foul diarrhoea, bloating, weight loss or eosinophilia after travel suggests Giardia, Strongyloides or another parasite, with immune suppression changing severity and testing.

Severe nutritional syndromeRed flag

Dehydration, oedema, profound anaemia, tetany, arrhythmia or neurological deficiency requires admission and cautious nutrition support while cause-specific tests proceed.

Investigations

  1. 01
    Upper endoscopy with duodenal histologyFirst step
    Why
    Obtain multiple proximal and distal duodenal biopsies for PAS staining and pathology when classic Whipple or another enteropathy is suspected.
    Interpretation and limitations
    PAS-positive macrophages support Whipple but are not perfectly specific; patchy or extra-intestinal disease can yield negative gut biopsies.
  2. 02
    Tropheryma whipplei PCR
    Why
    Use tissue and phenotype-directed sterile-site samples through microbiology or a reference laboratory, ideally confirming a positive result by an independent target or compartment.
    Interpretation and limitations
    Stool or saliva positivity alone may indicate carriage. A sterile-site positive result carries greater weight but still needs clinical correlation and contamination control.
  3. 03
    Stool enteric and parasite testing
    Why
    Provide travel country, dates, immune status, exposures and duration so the laboratory adds Giardia, Cryptosporidium, ova, cysts, parasites and targeted NAAT beyond routine panels.
    Interpretation and limitations
    A negative multiplex panel does not exclude organisms absent from it. Traditional microscopy sensitivity is limited and repeated or specialised samples may be advised.
  4. 04
    Malabsorption and immune profile
    Why
    Check FBC, ferritin, B12, folate, albumin, INR, calcium, magnesium, vitamin D, CRP, HIV with consent and coeliac serology while gluten is eaten.
    Interpretation and limitations

Differential diagnosis

01

Coeliac disease

Positive coeliac serology and typical villous histology without organism-specific PCR support immune enteropathy; PAS-positive macrophages require careful microbiological interpretation.

02

Inflammatory bowel or HIV-related disease

Endoscopic distribution, histology, immune status and targeted infection testing distinguish Crohn disease, opportunistic infection and HIV enteropathy.

03

Culture-negative endocarditis

Weight loss, arthralgia and cardiac findings may represent Whipple endocarditis even without diarrhoea; specialist blood and tissue PCR is needed.

Management

01WhippleMultisystem diagnostic pathwayFirst stepArthralgia plus malabsorption, neurological disease or culture-negative endocarditis makes T. whipplei plausible.+
  1. 1Stop diagnostic anchoring, review prior immunosuppression and involve gastroenterology, infection or microbiology and the organ-specific team.
  2. 2Obtain duodenal histology and reference PCR from the most informative compartments before antibiotics when safe, without delaying treatment for unstable CNS or cardiac disease.
  3. 3Confirm concordance and exclude PAS or PCR mimics before committing to prolonged therapy.
  4. 4Plan a CNS-penetrating induction and prolonged eradication regimen with relapse surveillance through specialists.
02TravelPersistent diarrhoea after travelMalabsorption or diarrhoea persists beyond an acute travel illness.+

Complications

01

Severe malabsorption

Villous and lymphatic dysfunction causes diarrhoea, weight loss, anaemia, oedema and multiple vitamin deficiencies if diagnosis is delayed.

02

Neurological and cardiac disease

Central nervous system infection, supranuclear gaze abnormalities and culture-negative endocarditis can cause irreversible disability or death.

03

Relapse after treatment

Persistent organisms in sanctuary sites can cause late neurological or systemic recurrence, requiring prolonged specialist therapy and follow-up.

Monitoring and follow-up

  • Track weight, stool, arthralgia, cognition, eye movement, cardiac status and the organ-specific baseline through Whipple treatment.
  • Monitor FBC, renal and liver profile and agent-specific toxicity during prolonged antimicrobials.
  • Repeat phenotype-directed PCR or imaging only through specialist strategy because persistent nucleic acid and relapse interpretation are complex.
  • Reassess micronutrients, albumin and refeeding electrolytes as absorption and intake recover.
  • For travel infection, confirm symptom resolution and perform clearance or public-health follow-up only when current organism guidance recommends it.
  • Maintain long-term review for Whipple relapse, especially new neurological, joint or cardiac symptoms years after apparent cure.

Special situations

Arthralgia may lead by years

The long interval before gut symptoms is a classic reason Whipple disease is mislabelled as inflammatory rheumatological disease.

Carriage weakens stool PCR

A positive non-sterile sample is a clue, not a diagnosis. Tissue or sterile-site concordance changes probability substantially.

Tropical is geography not pathology

The travel history directs a modern parasite and immune work-up; it should not substitute for one.

Steroids can reveal the mimic

Unexpected deterioration after immune therapy should prompt urgent reconsideration of Whipple, Strongyloides, TB and other occult infections.

Neurological relapse is devastating

CNS assessment at diagnosis and an adequately penetrating regimen matter even when diarrhoea dominates.

Common pitfalls

  1. 01

    Diagnosing Whipple disease from stool PCR alone.

  2. 02

    Assuming absence of diarrhoea excludes cardiac or neurological Whipple disease.

  3. 03

    Escalating biologic therapy in a multisystem mimic without infection review.

  4. 04

    Calling every chronic post-travel diarrhoea tropical sprue.

  5. 05

    Relying on a standard multiplex panel without giving travel and immune details.

  6. 06

    Giving folate alone before excluding B12 deficiency.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
Gastroenterology and hepatologyOriginal SBA

Arthritis before malabsorption

A patient has years of migratory seronegative arthralgia, new weight loss and diarrhoea, and worsened after immunosuppression. What is the best next step?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Gastroenterology and hepatology topics →
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • RCPath UK SMI ID10: Aerobic actinomycetesCurrent UK laboratory context for Tropheryma whipplei identification.
  • RCPath UK SMI S7: GastroenteritisCurrent 2026 travel, immune and parasite testing pathway.
  • BSG chronic diarrhoea guidelineMalabsorption, infection and small-bowel investigation.
  • BNF: Antibacterial drugsCurrent UK treatment safety and interaction context.
  • NICE CG32: Nutrition supportSevere malnutrition and refeeding prevention.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Treat severe dehydration, electrolyte depletion, malnutrition and refeeding risk immediately while diagnostic sampling continues.
Deficiency maps severity rather than cause; eosinophilia supports tissue-invasive helminth disease but can be absent, especially under corticosteroids.
  • 05
    CNS, cardiac or joint sampling
    Why
    Use MRI brain, CSF PCR, echocardiography, valve tissue, synovial fluid or ophthalmic sampling when extra-intestinal Whipple is plausible.
    Interpretation and limitations
    Negative blood and bowel tests do not rule out focal disease. Sampling risk and antibiotic timing need multidisciplinary planning.
  • 06
    Small-bowel imaging and repeat pathology review
    Why
    Assess lymphadenopathy, mural disease, obstruction, TB or lymphoma and request expert review when initial coeliac or inflammatory histology does not fit.
    Interpretation and limitations
    Imaging is nonspecific but identifies alternative diagnoses and safe biopsy targets; immunosuppression should wait when infection remains credible.
    • 1
    Map geography, onset, water, food, freshwater, soil, sexual exposure, antibiotics and immune suppression and assess hydration and refeeding risk.
  • 2Send stool with explicit travel details for UK SMI primary and targeted secondary testing, and screen coeliac, HIV and inflammatory alternatives by phenotype.
  • 3Treat a confirmed parasite with the current organism-specific UK regimen and notify or seek public-health advice when required.
  • 4Use endoscopy, small-bowel imaging and expert imported-infection review when routine testing is negative but objective malabsorption persists.
    • 03ProtectBefore immunosuppressionA seronegative inflammatory or granulomatous syndrome with weight loss, diarrhoea, nodes or unexplained neurological signs is being considered for stronger immune therapy.+
    1. 1Reassess infection and travel history and retrieve original tissue for expert review.
    2. 2Test for Whipple, TB, Strongyloides and other infections according to exposure and the proposed immunosuppressant.
    3. 3EscalationAvoid empirical corticosteroid escalation until dangerous infectious mimics are reasonably addressed, unless a competing emergency requires coordinated treatment.
    4. 4Document negative-test limitations and a monitoring plan because latent or focal infections may emerge after therapy.
    Key medicines and prescribing safety4 treatments · regimens, roles and cautions+
    Eradicates systemic T. whipplei and reduces neurological or cardiac relapse.

    Whipple disease antimicrobial regimen

    Specialist induction with a CNS-penetrating intravenous agent followed by prolonged oral eradication therapy, chosen through infection and microbiology guidance; verify current BNF and reference advice.

    Regimen and duration are not safely standardised from a summary. Check CNS involvement, interactions, cytopenia, renal or hepatic toxicity and late relapse; avoid brief empirical courses.

    Treats Giardia-associated persistent diarrhoea and malabsorption.

    Metronidazole or tinidazole for giardiasis

    Use the current BNF organism-specific adult regimen after laboratory or strongly supported imported-infection diagnosis.

    Alcohol advice, gastrointestinal effects, neuropathy with prolonged metronidazole and interactions matter. Reassess household or reinfection exposure and persistent symptoms.

    Treats Strongyloides and prevents catastrophic hyperinfection before or during immune suppression.

    Ivermectin for strongyloidiasis

    Specialist weight-based oral regimen according to current imported-infection guidance, with extended treatment for hyperinfection.

    Seek expert advice for severe disease, pregnancy and possible Loa loa exposure. Negative eosinophils do not exclude infection under corticosteroids.

    Corrects folate depletion and treats a residual tropical-sprue syndrome in an appropriate epidemiological setting.

    Folate with specialist antimicrobial therapy for tropical sprue

    Regimen and duration are specialist-selected only after infection, coeliac disease and other enteropathies are excluded.

    Check B12 before folate alone. The label should not replace organism-specific diagnosis, and prolonged tetracycline-class therapy has contraindications and interaction risks.